Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 5/20 | 0.59 |
| ▸ | NR0B2 | Q15466 | 2/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.57 |
| ▸ | RARB | P10826 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 6/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.44 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.44 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.44 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6022887 | 1.00 | PTPN11 (0.59) | PTPN11NR0B2HDAC11RARBKDM4E | |
| SCHEMBL6022855 | 0.90 | PTPN11 (0.58) | PTPN11NR0B2HDAC11RARBKDM4E | |
| SCHEMBL6022849 | 0.90 | PTPN11 (0.58) | PTPN11NR0B2HDAC11RARBKDM4E | |
| SCHEMBL2391857 | 0.90 | PTPN11 (0.48) | PTPN11NR0B2HDAC11RARBKDM4E | |
| SCHEMBL6023917 | 0.90 | HDAC11 (0.57) | PTPN11NR0B2HDAC11RARBKDM4E | |
| SCHEMBL6023909 | 0.90 | HDAC11 (0.57) | PTPN11NR0B2HDAC11RARBKDM4E | |
| SCHEMBL2391031 | 0.89 | HDAC11 (0.56) | PTPN11NR0B2HDAC11RARBKDM4E | |
| SCHEMBL6022648 | 0.88 | HDAC11 (0.57) | PTPN11NR0B2HDAC11RARBKDM4E | |
| SCHEMBL6022569 | 0.88 | HDAC11 (0.60) | PTPN11NR0B2HDAC11RARBKDM4E | |
| SCHEMBL6022603 | 0.88 | PTPN11 (0.68) | PTPN11NR0B2HDAC11RARBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7053071-B2 | For therapy of leukemia or other forms of cancer or for treating disease conditions caused by apoptosis of cells | THE BURNHAM INSTITUTE (US) | 2006-05-30 | — | — | US | disclosed |
| EP-1456165-A1 | INDUCTION OF APOPTOSIS IN CANCER CELLS | The Burnham Institute (US) | 2004-09-15 | — | — | EP | disclosed |
| US-20030176506-A1 | Induction of apoptosis in cancer cells | BURNHAM INSTITUTE FOR MEDICAL RESEARCH | 2003-09-18 | — | — | US | disclosed |
| WO-2003048101-A1 | INDUCTION OF APOPTOSIS IN CANCER CELLS | THE BURNHAM INSTITUTE (US) | 2003-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030176506-A1 | Induction of apoptosis in cancer cells | MCL1, BAD, BCL2 | PTPN11 2842/4885NR0B2 2377/4885HDAC11 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.